Arnold Kriegstein (UCSF) 2: Cerebral Organoids: Models of Human Brain Disease and Evolution

www.ibiology.org/neuroscience...
Dr. Arnold Kriegstein characterizes the development of neurons from radial glial cells and provides an overview of the use of cerebral organoids to study brain development and disease.
How do neurons develop to confer humans their unique brain functions? Dr. Arnold Kriegstein compares and contrasts the development of neurons from radial glial cells (RGCs) in mice and humans. In mice, RGCs give rise to most of the central nervous system’s neurons and glia and provide scaffolding for neurons to migrate. In contrast, human RGCs give rise to a unique set of cells, the outer subventricular zone radial glia (oRG) cells, which divide via mitotic somal translocation (MST). The oRG cells predominantly produce and guide the migration of the upper layer cortical neurons. Although rodents have oRG-like cells, these cells are more abundant in humans, and contribute to the large size of the human brain and possibly it’s unique function.
In his second talk, Kriegstein provides an overview of the use of cerebral organoids to study brain development and disease. Cerebral organoids are models that can be produced from induced pluripotent stem cells. Although organoids can contain the same broad categories of cell types found in the brain, organoids lack the structural, layer-like organization observed in the primary tissue. In addition, the gene expression profile is different between organoids and primary brain tissue. Nevertheless, although organoids do not reproduce all of the features of a developing human cortex, organoids can be a powerful model to study neuronal diseases and evolution, particularly when studying cells that cannot be found in animal models (e.g. oRG cells) or when scientists do not have access to primary brain tissue.
Speaker Biography:
Dr. Arnold Kriegstein is a Professor of Neurology at the University of California, San Francisco (UCSF) Weill Institute for Neurosciences, and Director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research. He obtained his bachelors in biology and psychology at Yale University (1971), and his medical and doctoral degrees at the New York University (1977) under the supervision of Dr. Eric Kandel. Kriegstein completed a residency in Neurology at the Brigham and Women’s Hospital, Children’s Hospital, and Beth Israel Hospital in Boston in 1981. He has held academic appointments at Stanford University (1981-1991), Yale University (1991-1993), and Columbia University (1993-2004). In 2004, Kriegstein joined the faculty in the Neurology Department at the University of California, San Francisco, where his lab studies the principles of neuronal development. In particular, they study how progenitor cells in the embryonic brain produce neurons. For his scientific contributions, he became a member of the National Academy of Medicine in 2008. Visit his lab website and learn more about Kriegstein’s research:
profiles.ucsf.edu/arnold.krie...

[@salvadorhirth1641]

Thanks, Dr. Arnold Kriegstein, for sharing knowledge.

[@brauliofernandesss]

Great talk, Dr. Arnold Kriegstein! Thanks for providing the references.

[@rajooananth4719]

Thx Sir

[@tyfoodsforthought]

Fantastic, I really enjoyed this. Brilliant use of organoids. It's kind of like "real life computational neuroscience", where you try to simulate the brain with actual neurons instead of artificial ones.

[@salvadorhirth1641]

One of the most difficult problems to create an effective therapy against cancers, is selectivity; another is multi drug resistance, where drugs are pumped out of cancer cells. I doubt that any cell would get rid of nutrients like amino acids; therefore, a trojan horse should be attempted to fight MDR cancers, especially aggressive tumors, that ought to absorb amino acids faster than surrounding healthy tissues: feed cancer cells with S35 labelled L-cysteine; the isotope of sulphur S35 would be used to assemble proteins, enzymes in cancer cells and at the moment the S35 would undergo beta decay, the transmutation " to the right " in the periodic table, would transform it into stable chlorine; disulfide bonds would be substituted by a HCl molecule that breaks peptide bonds. The energy released by S35 is very weak and it should not penetrate more than three milimeters around the isotopes, the idea is to use the chemical reactions triggered by the substitution of one element placed in a molecule. Other types of isotopes with electron capture transmutation or decay modey could also be attempted, but those have usually a very short half life. Carbon 14 has a half-life that exceeds 5300 years, but after absorbing one single neutron, the resulting isotope carbon 15 has a very short half-life; therefore, a new tool to treat a number of diseases could be possible, if an array of very narrow beams of neutrons could be focused on a tumor that absorbed nutrients labelled with carbon 14.

[@theultimatereductionist7592]

What is the primary protein sequence of amino acids that makes up MOST of a human's brain?
Is that even a well-defined question?

[@merlinmystique]

fucking Ghost in the shell shit. Amazing

[@faridehmoeinvaziri3515]

🌸🌸🌸👏👏👏

[@TheMartian11]

Never knew we had Orgy in our genes!

[@catminion1425]

BIV

[@gara5318]

"neuroscientists' ambitions to
model complex brain organization in organoids will require a
the lab to
significant printed organoidgoBolyrher try to reduce levels Scafföfdng stress. Biomimicry Of "Different groups have Anatomy how they culture organoids in lots
of different ways, so the fact that
we see these issues across
organoids from different
laboratories suggests it's probably"
3D printed Biopolymer scaffolding could work to organize brain components into their proper functioning configurations?

[@catminion1425]

Imperial Corp™

[@matthewbrennan3127]

First

[@shanesimon2495]

second

[@brainbook3035]

third